SCHEMBL2932471

SCHEMBL2932471

Nc1nc(NC2CCCN([N+]34C=C(c5ccc(Cl)cc5Cl)N=CC3=NC=N4)C2)ccc1C(=O)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IL1B P01584 1/20 0.33
GSK3B P49841 1/20 0.31
GPR6 P46095 1/20 0.31
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4281341 0.99 IL1B (0.32) IL1BGSK3BGPR6
SCHEMBL2932555 0.88
SCHEMBL4287394 0.85 GSK3B (0.34) IL1BGSK3BCNR1
SCHEMBL2934351 0.78 CCR6 (0.41) GSK3B
Hydrochloric Acid SCHEMBL4281663 0.78 CCR6 (0.41) GSK3B
SCHEMBL4284032 0.76 GSK3B (0.49) GSK3B
SCHEMBL2935929 0.75 GSK3B (0.33) GSK3B
SCHEMBL7956666 0.73 GSK3B (0.47) IL1BGSK3BGPR6CNR1
SCHEMBL3166285 0.73
Hydrochloric Acid SCHEMBL2247528 0.73 GSK3B (0.46) IL1BGSK3BGPR6CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229392-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE AS GSK3BETA INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2010-09-22 EP disclosed
WO-2009074259-A1 TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-06-18 WO disclosed